{
  "id": 67,
  "text": "[5]BU-UTUMUEVINEAaridialamlaltmyrrvil cinoma:Anovel surgical approach.Gynecol Oncol,2005,97(1):296-300.[6]LESTERCFARMERDLABBANJTtaladicaltrahletmyforclercellcamaftcrvx 6-yearlartvinrnftgilqiau018） 7]W.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: [5]BU-UTUMUEVINEAaridialamlaltmyrrvil cinoma:Anovel surgical approach.Gynecol Oncol,2005,97(1):296-300.[6]LESTERCFARMERDLABBANJTtaladicaltrahletmyforclercellcamaftcrvx 6-yearlartvinrnftgilqiau018） 7]W.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究，目前在宫颈癌的治疗中确实存在一种新的手术方法，例如“改良的广泛性宫颈切除术”（radical trachelectomy），它是一种针对早期宫颈癌患者的保守性手术方式。这种手术的目标在于尽可能保留患者的生育功能，同时彻底切除病灶，降低复发风险。具体应用需根据患者的病情分期、肿瘤大小、淋巴结受累情况等综合评估后决定。",
  "query": "**宫颈癌的治疗研究中是否存在一种新的手术方法？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **宫颈癌的治疗研究中是否存在一种新的手术方法？**\n\n<reference text>: [5]BU-UTUMUEVINEAaridialamlaltmyrrvil cinoma:Anovel surgical approach.Gynecol Oncol,2005,97(1):296-300.[6]LESTERCFARMERDLABBANJTtaladicaltrahletmyforclercellcamaftcrvx 6-yearlartvinrnftgilqiau018） 7]W.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究，目前在宫颈癌的治疗中确实存在一种新的手术方法，例如“改良的广泛性宫颈切除术”（radical trachelectomy），它是一种针对早期宫颈癌患者的保守性手术方式。这种手术的目标在于尽可能保留患者的生育功能，同时彻底切除病灶，降低复发风险。具体应用需根据患者的病情分期、肿瘤大小、淋巴结受累情况等综合评估后决定。"
}